Human antimicrobial peptides and cancer
Authors:
- 1 April 2019
- journal article
- review article
- Published by Elsevier in Seminars in Cell & Developmental Biology
- Vol. 88, 156-162
Abstract
No abstract availableKeywords
Funding Information
- NIH (R01DE025284, R56DE021046, 2R01DE018276, R56DE018276, P01DE019759)
This publication has 100 references indexed in Scilit:
- Pathobionts of the gastrointestinal microbiota and inflammatory diseaseCurrent Opinion in Immunology, 2011
- Fusobacterium nucleatum-associated β-Defensin Inducer (FAD-I)Journal of Biological Chemistry, 2010
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Immunity, Inflammation, and CancerCell, 2010
- Expression of human β-defensin-2 in intratumoral vascular endothelium and in endothelial cells induced by transforming growth factor βPeptides, 2010
- Inflammation and oncogenesis: a vicious connectionCurrent Opinion in Genetics & Development, 2010
- The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cellsProceedings of the National Academy of Sciences, 2009
- Cancer-related inflammationNature, 2008
- Studies on anticancer activities of antimicrobial peptidesBiochimica et Biophysica Acta (BBA) - Biomembranes, 2008
- Tumour-educated macrophages promote tumour progression and metastasisNature Reviews Cancer, 2004